Changes to the Executive Leadership Team
Date 12.21.2017 | Category: News
Ms. Havranek-Kosicek has up until November 2017 served as CFO and member of the Executive Board for Kuoni Group, a leading 8,000-employee service provider to the global travel industry. In the period 2011-2016 Ms. Havranek-Kosicek held positions at Royal DSM, including Group Treasurer and CFO for DSM’s pharmaceutical division, and from 2004-2008 she served as VP Corporate Subsidiaries and Investor Relations for Austrian Airlines Group.
Says CEO Peder Holk Nielsen: “With a strong business acumen from international positions around the world, a thorough understanding of the different finance functions and knowledge of Novozymes’ markets, Prisca brings the right competencies and drive to support our future growth. I'm very pleased to see her become part of our Executive Leadership Team.”
Ms. Prisca Havranek-Kosicek says: “I'm honored to join Novozymes, the global leader in biological solutions with a strong cultural heritage and values. What sets Novozymes apart is the company’s innovation track record and its commitment to help solve some of the pressing global challenges facing the world today. I look forward to working with the great people at Novozymes to continue this journey.”
Ms. Havranek-Kosicek will take part in the 2017-2019 Executive Leadership Team’s incentive program on a proportional basis from February 1, 2018. A description of this program, introduced on January 18, 2017, can be found in the “Group financial statement for 2016. Company announcement No. 1.” For more visit Novozymes.com
Source: NovozymesAuthor: COX